• 1. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Shanghai, 200433 P. R. China;
  • 2. Department of Thoracic Surgery, Ningbo Huamei Hospital, Chinese Academy of Sciences, Ningbo, 315000, Zhejiang, P. R. China;
  • 3. Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, P. R. China;
  • 4. Department of Thoracic Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China;
CHEN Chang, Email: chenthoracic@163.com
Export PDF Favorites Scan Get Citation

Compared to traditional suturing, lung stapling using automatic staplers offers advantages such as smaller trauma, faster wound healing, ease of operation, and lower complication rates, making it widely used in clinical practice. However, there are significant differences in bronchial tissue thickness at different anatomical locations, and the market is flooded with various types of staplers. Currently, there is a lack of recommended stapling schemes for bronchial staplers at different anatomical locations. This article reviews the development and application of automatic staplers and summarizes some types of staplers that are currently used in clinical practice, with the aim of promoting the formation of individualized stapler selection protocols for minimally invasive thoracic surgery based on the Chinese population.

Citation: LI Shenghui, REN Yijiu, SU Hang, YANG Minglei, ZHAO Guofang, SONG Yongxiang, HU Xuefei, ZHAO Deping, XUE Qi, CHEN Chang. Evaluation progress of the application of staplers in thoracoscopic lung surgery. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2025, 32(5): 709-713. doi: 10.7507/1007-4848.202408021 Copy

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved

  • Previous Article

    Risk factors of persistent cough after pneumonectomy: A systematic review and meta-analysis
  • Next Article

    Research progress on PD-1/PD-L1 inhibitors in neoadjuvant therapy for esophageal cancer